REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms > Polycyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > Bicyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > Isoquinolines (including Hydrogenated) Isoquinolines (including Hydrogenated)Isoquinolines (including Hydrogenated) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027182 - Octahydroisoquinoline compounds as opioid receptor modulators Compounds which bind to opioid receptors are provided. In a preferred embodiment of the invention, the compounds are opioid receptor antagonists. The present invention also provides methods of treating conditions which are mediated by an opioid receptor. ... 02/01/07 - 20070027181 - Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food or a pharmaceutically acceptable salt thereof. ... 11/23/06 - 20060264459 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds. ... 10/26/06 - 20060241137 - Triazole compounds and the therapeutic use thereof The invention relates to triazole compounds of general formula (I), wherein A, B, R1, R2, R3 and R4 have the meaning cited in claim 1. The invention also relates to a pharmaceutical agent containing at least one compound of general formula (I) in addition to the use of the compound ... 07/27/06 - 20060167043 - Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same wherein Q represents phenyl, pyridyl, pyrrolyl, thienyl, or furyl; these groups are optionally substituted by one or two halogens or alkyl, nitro, or amino groups; and p is 2 or 3. ... 06/29/06 - 20060142332 - 5-ht7 receptor antagonists The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT ... 06/22/06 - 20060135556 - Non-nucleoside reverse transcriptase inhibitors Various carbonyl amides are employed in vitro and in vivo as non-nucleoside inhibitors of a reverse transcriptase, and particularly of HIV reverse transcriptase. Therefore, contemplated compounds may be employed in the treatment of HIV infected patients. Further contemplated aspects include pharmaceutical compositions comprising therapeutically effective amounts of contemplated compounds. ... 06/01/06 - 20060116396 - 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents and their use as pharmaceutical agents. ... 05/25/06 - 20060111396 - 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin wherein R1-R8 for compounds of each of the formulae IA, IB, IC, ID, IE and IF are as described herein. ... 05/25/06 - 20060111395 - Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin wherein R1—R8 are as described herein, R4 being aryl or heteroaryl. ... 05/25/06 - 20060111394 - Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin wherein R1-R8 are as described herein, R4 being aryl or heteroaryl. ... 05/25/06 - 20060111393 - 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin wherein R1-R8 for compounds of each of the formulae IA, IB, IC, ID, IE and IF are as described herein. ... 01/26/06 - 20060019987 - Methods and compositions for inhibiting, destroying, and/or inactivating viruses The present disclosure provides compositions, methods, and processes for the inhibiting, destroying, and/or inactivating viral contaminants in a biological source material, or treatment of viral infections. The disclosed compositions include one or more quaternary ammonium compounds. One exemplary method includes contacting the biological source material with a solution containing one ... 01/05/06 - 20060004040 - Method for the prevention and/or treatment of atherosclerosis The instant invention provides a method for treating and/or reducing the risk for atherosclerosis comprising administering an effective amount of a FLAP inhibitor alone or in combination with another anti-atherosclerotic agent to a patient in need of such treatment. ... 12/29/05 - 20050288325 - Therapy for andropause using estrogen agonists/antagonists and testosterone The present invention concerns the treatment of andropause and related conditions using a combination of an estrogen agonist/antagonist and testosterone. ... 12/29/05 - 20050288324 - Aromatic sulfonamides as peroxynitrite-rearrangement catalysts The invention relates to the use of aromatics sulfonamides of the general formula I as peroxynitrite rearrangement catalysts, to the preparation thereof and to the use thereof as medicament for the treatment of various disorders. ... 12/01/05 - 20050267149 - Benzoic acid derivatives as modulators of ppar alpha and gamma A compound of formula (I) wherein R1 represents aryl optionally substituted by a heterocyclic group or a heterocyclic group optionally substituted by aryl wherein each aryl or heterocyclic group is optionally substituted; the group —CH2)m-T-(CH2)n—U—(CH2)p— is attached at either the 3 or 4 position in the phenyl ring as indicated ... 10/06/05 - 20050222199 - Process for the preparation of a hydrate of an antranilic acid derivative A hydrate of an acid addition bis-salt of an anthranilic acid derivative is produced by a process which comprises: (a) combining, in any order, the anthranalic acid derivative, a pharmaceutically acceptable organic solvent, an excess of water and a pharmaceutically acceptable strong acid to form a mixture; (b) warming the ... 06/30/05 - 20050143415 - Substituted pentanols, a process for their production and their use as anti-inflammatory agents The invention relates to substituted pentanols, a process for their production and their use as anti-inflammatory agents. ... ### FreshPatents.com Support |